CJC-1295 DAC is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The most common research dosage for CJC-1295 DAC is 1-2 mg per injection, administered once or twice weekly via subcutaneous injection. Typical cycles run 12-16 weeks. With a half-life of 6-8 days, timing matters for optimal results.
What Is CJC-1295 DAC and Why Does Dosing Matter?
CJC-1295 DAC (CJC-1295 with Drug Affinity Complex) is a GHRH analog with extended half-life. Synthetic GHRH analog with four amino acid substitutions conjugated to a drug affinity complex that binds endogenous albumin. Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.
The standard research dosage for CJC-1295 DAC has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.
What Is the Recommended CJC-1295 DAC Dosage?
The most widely used CJC-1295 DAC dosage is 1-2 mg per injection, administered once or twice weekly via subcutaneous injection.
Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of CJC-1295 DAC is 6-8 days, which directly determines how often you need to dose to maintain stable blood levels.
For CJC-1295 DAC specifically, the 12-16 weeks cycle length is standard. Longer isn't always better — GHRH analog with extended half-life compounds require cycling to maintain receptor sensitivity.
When Should You Dose CJC-1295 DAC?
With a half-life of 6-8 days, timing your CJC-1295 DAC administration affects peak blood levels. Most protocols call for once or twice weekly.
For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.
Calculate Your CJC-1295 DAC Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for CJC-1295 DAC.
Open Calculator →How Do You Reconstitute CJC-1295 DAC?
CJC-1295 DAC typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.
Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.
How Long Should a CJC-1295 DAC Cycle Last?
Standard CJC-1295 DAC cycles run 12-16 weeks. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.
Single dose increases plasma GH 2-10 fold for 6+ days and IGF-1 0.5-3 fold for 9-11 days in humans. Multiple clinical trials demonstrated sustained dose-dependent GH/IGF-1 elevation. Reached Phase II before discontinuation.
What Side Effects Can Affect Dosing?
Water retention, joint aches, fluid retention, mild headache. Sustained GH elevation may cause more pronounced side effects than pulsatile release versions. One subject death in Phase II trial was attributed to unrelated coronary artery disease.
If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most CJC-1295 DAC-related side effects are dose-dependent.
How Does CJC-1295 DAC Dosing Change When Stacking?
Synergizes with GHRP-6 or GHRP-2 for amplified GH pulse amplitude. The sustained release makes it less ideal for stacking than CJC-1295 no DAC, which preserves natural pulsatility.
When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.
What Is the Bottom Line on CJC-1295 DAC Dosing?
Start at 1, dose once or twice weekly, and run cycles of 12-16 weeks. Monitor your response and adjust within the established range.
Source matters — always use research-grade CJC-1295 DAC from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.
Complete Guide
CJC-1295 DAC : Benefits, Dosage, Side Effects & Research
Related Reading
- CJC-1295 DAC Benefits
- CJC-1295 DAC Side Effects
- CJC-1295 DAC Stacking Guide
- CJC-1295 DAC Cycle Guide
- CJC-1295 DAC Research
- CJC-1295 Complete Guide
Research-Grade Sourcing
If you're going to research CJC-1295 DAC, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is CJC-1295 DAC?
CJC-1295 DAC (CJC-1295 with Drug Affinity Complex) is a GHRH analog with extended half-life. Synthetic GHRH analog with four amino acid substitutions conjugated to a drug affinity complex that binds endogenous albumin. It is researched for sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass.
What is the recommended CJC-1295 DAC dosage?
Common dosages: 1-2 mg per injection administered once or twice weekly via subcutaneous injection. Cycle length: 12-16 weeks. Half-life: 6-8 days. Use our peptide calculator for exact reconstitution math.
What are the side effects of CJC-1295 DAC?
Water retention, joint aches, fluid retention, mild headache. Sustained GH elevation may cause more pronounced side effects than pulsatile release versions. One subject death in Phase II trial was attributed to unrelated coronary artery disease.
Is CJC-1295 DAC safe?
CJC-1295 DAC has shown a preliminary safety profile in research. Not FDA-approved. Development discontinued post-Phase II. WADA banned. Available as research peptide. All research should follow appropriate safety protocols.